+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Alexion Pharmaceuticals - logo

Alexion is a global biopharmaceutical company focused on developing and delivering life-transforming therapies for patients with devastating and rare diseases. Alexion developed Soliris for the treatment of patients with paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome. Soliris is approved in more than 50 countries for PNH and more than 40 countries for aHUS. Alexion's company headquarters are based Cheshire, Connecticut, United States.

North America Myasthenia Gravis Treatment Market Size, Share & Industry Trends Analysis Report By End-use (Hospitals, Clinics and Others), By Type, By Country and Growth Forecast, 2023 - 2030 - Product Thumbnail Image

North America Myasthenia Gravis Treatment Market Size, Share & Industry Trends Analysis Report By End-use (Hospitals, Clinics and Others), By Type, By Country and Growth Forecast, 2023 - 2030

  • Report
  • November 2023
  • 107 Pages
  • North America
From
Europe Myasthenia Gravis Treatment Market Size, Share & Industry Trends Analysis Report By End-use (Hospitals, Clinics and Others), By Type, By Country and Growth Forecast, 2023 - 2030 - Product Thumbnail Image

Europe Myasthenia Gravis Treatment Market Size, Share & Industry Trends Analysis Report By End-use (Hospitals, Clinics and Others), By Type, By Country and Growth Forecast, 2023 - 2030

  • Report
  • November 2023
  • 116 Pages
  • Europe
From
Global Transthyretin Amyloidosis Treatment Market Report and Forecast 2023-2031 - Product Thumbnail Image

Global Transthyretin Amyloidosis Treatment Market Report and Forecast 2023-2031

  • Report
  • March 2023
  • 147 Pages
  • Global
From
Mucopolysaccharidosis III - Pipeline Insight, 2024 - Product Thumbnail Image

Mucopolysaccharidosis III - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 50 Pages
  • Global
From
Complement C5 inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

Complement C5 inhibitors - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Blood Disorder Therapeutics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027) - Product Thumbnail Image

Blood Disorder Therapeutics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

  • Report
  • January 2022
  • 115 Pages
  • Global
From
Age Related Macular Degeneration Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Age Related Macular Degeneration Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • December 2022
  • 289 Pages
  • Global
From
Biotechnology Services Global Market Report 2024 - Product Thumbnail Image

Biotechnology Services Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Bioinformatic Collaboration and Licensing Deals 2016-2024 - Product Thumbnail Image

Bioinformatic Collaboration and Licensing Deals 2016-2024

  • Report
  • May 2024
  • 650 Pages
  • Global
From
Biotech Ingredient Global Market Report 2024 - Product Thumbnail Image

Biotech Ingredient Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Smart Life Sciences Manufacturing Global Market Report 2024 - Product Thumbnail Image

Smart Life Sciences Manufacturing Global Market Report 2024

  • Report
  • January 2024
  • 175 Pages
  • Global
From
Glomerulonephritis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Glomerulonephritis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • June 2022
  • 230 Pages
  • Global
From
Liver Transplant Rejection Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Liver Transplant Rejection Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • June 2022
  • 49 Pages
  • Global
From
Liver Transplant Rejection - Pipeline Review, H2 2020 - Product Thumbnail Image

Liver Transplant Rejection - Pipeline Review, H2 2020

  • Drug Pipelines
  • September 2020
  • 73 Pages
  • Global
From
Allergic Conjunctivitis - Pipeline Review, H2 2020 - Product Thumbnail Image

Allergic Conjunctivitis - Pipeline Review, H2 2020

  • Drug Pipelines
  • October 2020
  • 113 Pages
  • Global
From
Paroxysmal Nocturnal Hemoglobinuria Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Paroxysmal Nocturnal Hemoglobinuria Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • June 2022
  • 131 Pages
  • Global
From
Dermatomyositis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Dermatomyositis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • October 2022
  • 64 Pages
  • Global
From
Global Proteomics Partnering Terms and Agreements 2010 to 2023 - Product Thumbnail Image

Global Proteomics Partnering Terms and Agreements 2010 to 2023

  • Report
  • June 2023
  • 400 Pages
  • Global
From
Injectable Drug Delivery Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update - Product Thumbnail Image

Injectable Drug Delivery Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update

  • Report
  • December 2023
  • 492 Pages
  • Global
From
Hypercholesterolemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Hypercholesterolemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • October 2022
  • 210 Pages
  • Global
From
Loading Indicator